CDMO News
SPI Pharma and Inimmune Partner on Vaccine Adjuvant Development
SPI Pharma and Inimmune Corp. have announced a partnership to develop and commercialise advanced adjuvant systems for vaccine development. The collaboration leverages Inimmune’s expertise in adjuvant formulation and immunotherapeutics alongside SPI Pharma’s manufacturing and global commercial capabilities. Adjuvant systems are
17 July 2024